Hepatitis C Drug Makers Start Price War Although They Promised Not To

January 10, 2015 12:26 AM

4 0

AbbVie Inc. and Gilead Sciences Inc., the only hepatitis C drug makers , have already begun offering consistent discounts on their products to health insurance providers across the U.S. Both companies said last year that they weren’t planning get involved in a price war in 2015. However, business is business.

Yesterday, Anthem Inc, the most important provider of health insurance plans in the U.S., said that it had struck a deal with one of the two drug makers in exchange of cheaper hepatitis C drugs. Anthem Inc is the third insurer to publicly announce an exclusive deal with one of the pharma companies.

Read more

To category page